Ellen Cahir-McFarland Just a few days into her new job, Ellen Cahir-McFarland’s office is being emptied.
Cahir-McFarland, formerly head of research at Annexon, is the new chief scientific officer of Abata Therapeutics, a preclinical biotech that’s developing regulatory T cell, or Treg,...
